CAS 210302-17-3

BAM 15

CAS : 210302-17-3

BAM 15 is an uncoupler of mitochondrial protonophore.

Formule : C₁₆H₁₀F₂N₆O

Degré de pureté : 99.75% - 99.92%

Couleur et forme : Solid

Masse moléculaire : 340.29

Ref: TM-T14497

N-[6-(2-Fluoroanilino)[1,2,5]oxadiazolo[3,4-b]pyrazin-5-yl]-N-(2-fluorophenyl)amine

CAS : 210302-17-3

Formule : C₁₆H₁₀F₂N₆O

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 340.2870

Ref: IN-DA00J9K9

BAM 15

CAS : 210302-17-3

BAM 15

Degré de pureté : ≥98%

Masse moléculaire : 340.29g/mol

Ref: 54-BUP13227

BAM 15

CAS : 210302-17-3

Formule : C₁₆H₁₀F₂N₆O

Degré de pureté : >95.0%(HPLC)

Couleur et forme : White to Light yellow powder to crystal

Masse moléculaire : 340.29

Ref: 3B-B6594

BAM 15

CAS : 210302-17-3

BAM15 is a pharmacological agent that acts on mitochondrial membrane potential. It binds to the mitochondrial membrane and blocks proton flow, leading to the inhibition of cellular respiration. This leads to an increase in reactive oxygen species (ROS) production and mitochondrial membrane depolarization. BAM15 has been shown to have beneficial effects on hepatic steatosis and physiological changes in rats. It has also been shown to be effective against bowel diseases like colitis and necrotizing enterocolitis in vivo models. BAM15 is a promising drug for the treatment of congestive heart failure due to its ability to inhibit ATP synthesis in cardiac myocytes.

Formule : C₁₆H₁₀F₂N₆O

Degré de pureté : Min. 95%

Masse moléculaire : 340.29 g/mol

Ref: 3D-KIA30217